Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: a study of 56 patients

Related Experiment Videos

F M Santorelli1, M Sciacco, K Tanji

  • 1H. Houston Merritt Clinical Research Center for Muscular Dystrophy and Related Diseases--Department of Neurology, Columbia University, New York, NY, USA.

Annals of Neurology
|June 1, 1996
PubMed

Insights

Mitochondrial DNA deletions are common in inclusion body myositis, a muscle disorder affecting older adults. These genetic alterations may accelerate disease progression, suggesting a role in sporadic inclusion body myositis pathogenesis.

Area of Science:

  • Neurology
  • Genetics
  • Mitochondrial Biology

Background:

  • Inclusion body myositis (IBM) is the most frequent myopathy in adults over 50.
  • Diagnosis relies on clinical presentation and microscopy.
  • The etiology of IBM remains unclear, though mitochondrial DNA (mtDNA) deletions are suspected.

Purpose of the Study:

  • To investigate the frequency and distribution of mtDNA deletions in sporadic IBM.
  • To correlate mtDNA deletions with clinical and morphological findings.

Main Methods:

  • Studied 56 sporadic IBM patients using clinical, morphological, biochemical, and molecular genetic analyses.
  • Employed polymerase chain reaction (PCR) to detect mtDNA deletions.
  • Examined ragged-red fibers and cytochrome c oxidase activity.

Main Results:

  • Multiple mtDNA deletions found in 73% of IBM patients, versus 40% in controls.
  • Deletions correlated with ragged-red fibers and defects in electron transport chain complexes I and IV.
  • mtDNA alterations may be accelerated in IBM, beyond age-related changes.

Conclusions:

  • Multiple mtDNA deletions are frequent in sporadic IBM.
  • These deletions are associated with specific pathological features and biochemical defects.
  • Accelerated mtDNA alterations may contribute to IBM pathogenesis.

Related Concept Videos